# Adaptive Biotechnologies Corp: filings

ADPT · Nasdaq · CIK 1478320 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/adpt.md) · [Financials](/companies/adpt/financials.md) · [Filings](/companies/adpt/filings.md) · [Insiders](/companies/adpt/insiders.md)

## Reports and events: 113 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 493, 144 87, 8-K 70, 3 32, 10-Q 22, SC 13G/A 14, SC 13G 12, 4/A 11, DEFA14A 9, SCHEDULE 13G/A 9, D 8, 10-K 7, CORRESP 7, DEF 14A 7, ARS 4, S-1/A 4, UPLOAD 4, S-8 3, 424B4 2, 424B5 2, DRS 2, EFFECT 2, S-1 2, SEC STAFF LETTER 2, 144/A 1, 424B7 1, 5 1, 8-A12B 1, 8-K/A 1, CERT 1, D/A 1, DRS/A 1, DRSLTR 1, S-3ASR 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-04 | 16:30 ET | [10-Q](/filings/0001193125-26-332940.md) | Quarterly report, period 2026-06-30 | 0001193125-26-332940 |
| 2026-07-29 | 16:15 ET | [8-K](/filings/0001193125-26-323753.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-323753 |
| 2026-06-22 | 16:07 ET | [8-K](/filings/0001193125-26-277516.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-277516 |
| 2026-06-15 | 16:15 ET | [8-K](/filings/0001193125-26-271117.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-271117 |
| 2026-06-09 | 16:30 ET | [8-K](/filings/0001193125-26-263844.md) | 5.07 Shareholder vote results | 0001193125-26-263844 |
| 2026-05-05 | 16:30 ET | [10-Q](/filings/0001193125-26-206546.md) | Quarterly report, period 2026-03-31 | 0001193125-26-206546 |
| 2026-05-05 | 16:15 ET | [8-K](/filings/0001193125-26-206455.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-206455 |
| 2026-04-24 | 16:30 ET | [DEF 14A](/filings/0001193125-26-177409.md) | Proxy statement, period 2026-06-05 | 0001193125-26-177409 |
| 2026-02-26 | 16:31 ET | [10-K](/filings/0001193125-26-076902.md) | Annual report, period 2025-12-31 | 0001193125-26-076902 |
| 2026-02-05 | 16:15 ET | [8-K](/filings/0001193125-26-039409.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-039409 |
| 2026-01-12 | 08:15 ET | [8-K](/filings/0001193125-26-009840.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009840 |
| 2025-12-30 | 08:00 ET | [8-K](/filings/0001193125-25-335921.md) | 8.01 Other events | 0001193125-25-335921 |
| 2025-11-05 | 16:31 ET | [10-Q](/filings/0001193125-25-267061.md) | Quarterly report, period 2025-09-30 | 0001193125-25-267061 |
| 2025-11-05 | 16:15 ET | [8-K](/filings/0001193125-25-266974.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-266974 |
| 2025-08-18 | 08:00 ET | [8-K](/filings/0001193125-25-182222.md) | 1.02 Termination of a material agreement | 0001193125-25-182222 |
| 2025-08-05 | 16:31 ET | [10-Q](/filings/0000950170-25-103120.md) | Quarterly report, period 2025-06-30 | 0000950170-25-103120 |
| 2025-08-05 | 16:15 ET | [8-K](/filings/0000950170-25-103058.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-103058 |
| 2025-06-12 | 16:51 ET | [8-K](/filings/0001193125-25-140017.md) | 5.07 Shareholder vote results | 0001193125-25-140017 |
| 2025-05-01 | 16:30 ET | [10-Q](/filings/0000950170-25-061897.md) | Quarterly report, period 2025-03-31 | 0000950170-25-061897 |
| 2025-05-01 | 16:15 ET | [8-K](/filings/0000950170-25-061851.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-061851 |
| 2025-04-29 | 16:02 ET | [DEF 14A](/filings/0001193125-25-103752.md) | Proxy statement, period 2025-06-10 | 0001193125-25-103752 |
| 2025-03-03 | 16:36 ET | [10-K](/filings/0000950170-25-030913.md) | Annual report, period 2024-12-31 | 0000950170-25-030913 |
| 2025-02-11 | 16:15 ET | [8-K](/filings/0000950170-25-017915.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-017915 |
| 2024-11-07 | 16:30 ET | [10-Q](/filings/0000950170-24-123423.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123423 |
| 2024-11-07 | 16:15 ET | [8-K](/filings/0000950170-24-123369.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123369 |
| 2024-08-01 | 16:30 ET | [10-Q](/filings/0000950170-24-089342.md) | Quarterly report, period 2024-06-30 | 0000950170-24-089342 |
| 2024-08-01 | 16:15 ET | [8-K](/filings/0000950170-24-089301.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-089301 |
| 2024-06-11 | 16:15 ET | [8-K](/filings/0000950170-24-071913.md) | 5.07 Shareholder vote results; 8.01 Other events | 0000950170-24-071913 |
| 2024-05-07 | 16:30 ET | [10-Q](/filings/0000950170-24-054604.md) | Quarterly report, period 2024-03-31 | 0000950170-24-054604 |
| 2024-05-07 | 16:15 ET | [8-K](/filings/0000950170-24-054513.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-054513 |
| 2024-04-26 | 16:31 ET | [DEF 14A](/filings/0001193125-24-118168.md) | Proxy statement, period 2024-06-07 | 0001193125-24-118168 |
| 2024-04-09 | 17:29 ET | [8-K](/filings/0001193125-24-090983.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-090983 |
| 2024-04-05 | 16:30 ET | [8-K](/filings/0000950170-24-042291.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-042291 |
| 2024-04-02 | 16:06 ET | [8-K](/filings/0001193125-24-084748.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-084748 |
| 2024-02-29 | 16:15 ET | [10-K](/filings/0000950170-24-023095.md) | Annual report, period 2023-12-31 | 0000950170-24-023095 |
| 2024-02-14 | 16:15 ET | [8-K](/filings/0000950170-24-015230.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-015230 |
| 2023-11-09 | 16:30 ET | [10-Q](/filings/0000950170-23-062136.md) | Quarterly report, period 2023-09-30 | 0000950170-23-062136 |
| 2023-11-09 | 16:15 ET | [8-K](/filings/0000950170-23-062077.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062077 |
| 2023-09-01 | 17:16 ET | [8-K](/filings/0001193125-23-227739.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-227739 |
| 2023-08-02 | 16:31 ET | [10-Q](/filings/0000950170-23-037234.md) | Quarterly report, period 2023-06-30 | 0000950170-23-037234 |
| 2023-08-02 | 16:17 ET | [8-K](/filings/0000950170-23-037192.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-037192 |
| 2023-07-03 | 15:14 ET | [8-K](/filings/0001193125-23-181293.md) | 3.01 Delisting notice | 0001193125-23-181293 |
| 2023-06-13 | 16:30 ET | [8-K](/filings/0000950170-23-027702.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000950170-23-027702 |
| 2023-05-09 | 07:38 ET | [8-K](/filings/0001193125-23-138915.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-138915 |
| 2023-05-03 | 16:32 ET | [10-Q](/filings/0000950170-23-017250.md) | Quarterly report, period 2023-03-31 | 0000950170-23-017250 |
| 2023-05-03 | 16:16 ET | [8-K](/filings/0000950170-23-017194.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-017194 |
| 2023-04-28 | 16:01 ET | [DEF 14A](/filings/0001193125-23-126845.md) | Proxy statement | 0001193125-23-126845 |
| 2023-04-11 | 10:55 ET | [8-K](/filings/0001193125-23-097389.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-097389 |
| 2023-02-14 | 16:32 ET | [10-K](/filings/0000950170-23-002792.md) | Annual report, period 2022-12-31 | 0000950170-23-002792 |
| 2023-02-14 | 16:15 ET | [8-K](/filings/0000950170-23-002786.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-002786 |

Page 1 of 3. [Older](/companies/adpt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 19:53 ET. No prices; not investment advice.